» Articles » PMID: 36291201

Identification and Characterization of Elevated Expression of Transferrin and Its Receptor TfR1 in Mouse Models of Depression

Overview
Journal Brain Sci
Publisher MDPI
Date 2022 Oct 27
PMID 36291201
Authors
Affiliations
Soon will be listed here.
Abstract

Depression has become one of the severe mental disorders threatening global human health. In this study, we first used the proteomics approach to obtain the differentially expressed proteins in the liver between naive control and chronic social defeat stress (CSDS) induced depressed mice. We have identified the upregulation of iron binding protein transferrin (TF) in the liver, the peripheral blood, and the brain in CSDS-exposed mice. Furthermore, bioinformatics analysis of the Gene Expression Omnibus (GEO) database from various mouse models of depression revealed the significantly upregulated transcripts of and its receptor in multiple brain regions in depressed mice. We also used the recombinant TF administration via the tail vein to detect its permeability through the blood-brain barrier (BBB). We demonstrated the permeability of peripheral TF into the brain through the BBB. Together, these results identified the elevated expression of TF and its receptor TfR1 in both peripheral liver and the central brain in CSDS-induced depressed mice, and peripheral administration of TF can be transported into the brain through the BBB. Therefore, our data provide a compelling information for understanding the potential role and mechanisms of the cross-talk between the liver and the brain in stress-induced depression.

Citing Articles

Tyrosine phosphatase SHP2 promoted the progression of CRC via modulating the PI3K/BRD4/TFEB signaling induced ferroptosis.

Chen J, Li W, Zhang C, Wen D, Jiao C Discov Oncol. 2024; 15(1):793.

PMID: 39692787 PMC: 11655821. DOI: 10.1007/s12672-024-01586-w.


Social defeat stress impairs systemic iron metabolism by activating the hepcidin-ferroportin axis.

Kasahara E, Nakamura A, Morimoto K, Ito S, Hori M, Sekiyama A FASEB Bioadv. 2024; 6(8):263-275.

PMID: 39114446 PMC: 11301257. DOI: 10.1096/fba.2024-00071.


T cell activation and deficits in T regulatory cells are associated with major depressive disorder and severity of depression.

Rachayon M, Jirakran K, Sodsai P, Sughondhabirom A, Maes M Sci Rep. 2024; 14(1):11177.

PMID: 38750122 PMC: 11096341. DOI: 10.1038/s41598-024-61865-y.


Exploring Potential Mechanisms Accounting for Iron Accumulation in the Central Nervous System of Patients with Alzheimer's Disease.

Levine S Cells. 2024; 13(8.

PMID: 38667304 PMC: 11049304. DOI: 10.3390/cells13080689.


Ferroptosis: a new antidepressant pharmacological mechanism.

Zhang G, Lv S, Zhong X, Li X, Yi Y, Lu Y Front Pharmacol. 2024; 14:1339057.

PMID: 38259274 PMC: 10800430. DOI: 10.3389/fphar.2023.1339057.


References
1.
Fernandez J, Gharahdaghi F, Mische S . Routine identification of proteins from sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels or polyvinyl difluoride membranes using matrix assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS). Electrophoresis. 1998; 19(6):1036-45. DOI: 10.1002/elps.1150190619. View

2.
Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M . The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55(4):611-22. DOI: 10.1373/clinchem.2008.112797. View

3.
Castren E, Monteggia L . Brain-Derived Neurotrophic Factor Signaling in Depression and Antidepressant Action. Biol Psychiatry. 2021; 90(2):128-136. DOI: 10.1016/j.biopsych.2021.05.008. View

4.
Ferreira A, Neves P, Gozzelino R . Multilevel Impacts of Iron in the Brain: The Cross Talk between Neurophysiological Mechanisms, Cognition, and Social Behavior. Pharmaceuticals (Basel). 2019; 12(3). PMC: 6789770. DOI: 10.3390/ph12030126. View

5.
Ewert A, Chang Y . Levels of Nature and Stress Response. Behav Sci (Basel). 2018; 8(5). PMC: 5981243. DOI: 10.3390/bs8050049. View